Moderna Shares Brace for Volatility Ahead of Third-Quarter Earnings

By EC Assets · Published 30 October 2026

Moderna shares face an estimated 6% price swing following the scheduled release of the company's financial results next week. The stock settled at $245.81 during its latest trading day, representing a 1.54% change from its previous close. That advance allowed Moderna, which trades under the ticker symbol MRNA, to rise higher than the broader market over the session. The projected 6% post-earnings movement precedes a critical financial disclosure for the biotechnology firm. Moderna's third-quarter earnings are expected to decline in the upcoming quarterly report. The company does not possess the right combination of the two key ingredients required for a likely earnings beat in this release. Investors are preparing for these key expectations as the biotechnology company approaches its announcement date next week. The anticipated release from Moderna takes place alongside third-quarter results across other major industries, including energy and technology. In the energy sector, Chevron and Exxon both beat consensus earnings expectations as refining profits soared on the back of high diesel fuel prices. Furthermore, one slide in an investor presentation delivered by ExxonMobil after its third-quarter earnings explained the financial situation for integrated oil giants, documenting the forecast-beating earnings achieved by Exxon, Chevron, and BP. By contrast, communication and social media companies experienced steep post-earnings declines. Shares in the online discussion platform Reddit tumbled 25% on Friday morning after the company issued a lower-than-expected revenue outlook. That sharp decline put Reddit shares on track for their biggest-ever one-day drop, with further bad news projected to follow. The semiconductor market also faced downward pressure connected to quarterly disclosures. Shares of Advanced Micro Devices slid after earnings from Intel revealed two big operational issues. Intel disclosed that it is struggling to make enough artificial intelligence server chips while simultaneously dealing with a weak personal computer market. Investors will soon find out the degree to which AMD may be suffering from the same problems in its own operations. Executive messaging regarding artificial intelligence also surfaced across multiple quarterly presentations. Elon Musk and Mark Zuckerberg echoed Donald Trump's push to rebrand artificial intelligence as super intelligence during their earnings calls, while other executives on quarterly calls did not adopt that framing. These corporate developments arrive as midterm elections, a wave of earnings reports, and upcoming jobs data loom over a market that remains wary of artificial intelligence investments. Moderna is scheduled to release its third-quarter earnings next week, revealing whether the company meets its lower profit expectations and whether the projected 6% price movement takes place. This article is intended for informational purposes only. It does not constitute investment advice.